Malignancy clinical trials

Explore recruiting malignancy clinical trials.

Recruiting malignancy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Malignancy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Long-term Follow-up Study of Subjects With Malignancies Treated With CRISPR CAR Cellular Therapies

Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

DETECTION RATE AND CLASSIFICATION OF BREAST LESIONS WITH DIGITAL MAMMOGRAPHY WITH CONTRAST MEDIUM (CEDM) ALONE AND IN COMBINATION WITH TOMOSYNTHESIS COMPARED TO MR IMAGING WITH GADOLINIUM IN DYNAMICS (DCE-MRI) - CEDM-MRI

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

TRIANGLE - autologous Transplantation after a Rituximab/Ibrutinib/Ara-c containing iNduction in Generalized mantle cell Lymphoma – a randomized European mcl network trial

Norway, Spain, Poland, Czechia, Sweden, Belgium +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

MIBI-THYR : Value of the combination ultrasonography with Ti-RADS score / dual tracer scintigraphy MIBI-Tc99m/Iodine-123 in the detection of malignancy of thyroid nodules (≥15 mm) classified Bethesda III or IV on cytology

France

Phase II and Phase III (Integrated) EU CTIS Study details

FORMAT Study : Use of fibrinogen in the treatment of bleeding in thrombopenic patients after intensive chemotherapy refractory to platelet transfusion - evaluation by rotem viscoelastometry (pilot single-center study).

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Fecal Microbiota Transplantation in the prevention of complications after allogeneic hematopoietic stem cell transplantation for hematologic malignancy

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Malignancy trials by city

Malignancy in Toronto Malignancy in Vancouver Malignancy in Montreal Malignancy in Calgary Malignancy in Edmonton Malignancy in Ottawa Malignancy in Winnipeg Malignancy in Quebec City Malignancy in Hamilton Malignancy in Kitchener Malignancy in London Malignancy in Halifax Malignancy in New York Malignancy in Los Angeles Malignancy in Chicago Malignancy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease